Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

19 Feb 2026 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated February 19, 2026, titled ‘Zydus launches biosimilar Aflibercept 2 mg ANYRA for advancing ophthalmic care’.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..